Magungunan ƙwayar cuta na MDMA na iya rage alamun bayyanar cututtuka na damuwa bayan tashin hankali, masu bincike sun ruwaito a cikin wani sabon binciken da aka buga ranar Alhamis.
Kamfanin da ke daukar nauyin binciken ya ce yana shirin neman amincewar Amurka nan gaba a wannan shekara don tallata maganin a matsayin magani don magance PTSD tare da maganin magana.
"Wannan shine sabon abu na farko a cikin maganin PTSD a cikin fiye da shekaru ashirin. Yana da mahimmanci saboda ina tsammanin zai kuma haifar da wasu sabbin abubuwa, "in ji Amy Emerson, Shugaba na Kamfanin Amfani da Jama'a na MAPS, mai daukar nauyin binciken, a cewar AP News.
Halatta MDMA
A farkon wannan shekarar, Ostiraliya ta zama ƙasa ta farko da ta sami likitocin tabin hankali MDMA da psilocybin, sinadarai masu aikin psychoactive a cikin namomin kaza na psychedelic. Magungunan suna samun karɓuwa a cikin Amurka, godiya a cikin wani ɓangare na ƙoƙarin ƙungiyar da ba ta riba ba Multidisciplinary Association for Psychedelic Studies.
Don sabon binciken, masu bincike sun auna alamun bayyanar cututtuka a cikin mutane 104 tare da PTSD, waɗanda aka ba da izini don karɓar MDMA ko kwaya na karya don zaman uku, wata daya baya. Dukansu ƙungiyoyi sun sami maganin magana.
Abubuwan da ke faruwa a cikin ƙungiyar MDMA sun haɗa da ciwon tsoka, tashin zuciya, rage cin abinci da gumi. Amma mutum ɗaya ne kawai daga ƙungiyar MDMA ya fita daga binciken. Bayan jiyya, 86% na ƙungiyar MDMA sun inganta akan daidaitattun ƙima na PTSD, idan aka kwatanta da 69% na ƙungiyar placebo. Gwajin yana auna alamomin kamar su mafarki mai ban tsoro, sake dawowa da rashin barci.
A ƙarshen binciken, 72% na mutanen da ke cikin ƙungiyar MDMA ba su cika ka'idodin bincike na PTSD ba, idan aka kwatanta da kusan 48% na rukunin placebo. "Sakamakon da suka samu yana da ban sha'awa sosai," in ji Barbara Rothbaum, wanda ke jagorantar Shirin Tsohon Sojoji na Lafiya na Emory a Atlanta. Ba ta shiga cikin binciken ba, wanda aka buga a cikin mujallar Nature Medicine.
Magungunan rigakafin rauni
Hakanan ana iya bi da PTSD tare da wasu magunguna tare da maganin magana. Duk da haka, wannan baya aiki ga kowa da kowa ko wani mataki na juriya na iya faruwa a cikin marasa lafiya. "Magungunan kwayoyi suna da tasiri sosai, amma babu abin da ke da tasiri 100%," in ji Rothbaum. "Don haka tabbas muna buƙatar ƙarin zaɓuɓɓukan magani."
Kafin a iya rubuta MDMA a cikin Amurka, Hukumar Abinci da Magunguna (FDA) za ta amince da shi kuma Hukumar Kula da Magunguna za ta canza rabe-rabenta. MDMA a halin yanzu ana rarraba shi azaman Jadawalin 1, kama da tabar heroin, kuma ana ɗaukarsa da "ba a yarda da amfani da magani a halin yanzu da babban yuwuwar zagi."
Source: APNews.com (En)
